Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 08 2025
0mins
Source: Globenewswire
Financial Performance: Arcadia Biosciences reported a 22% increase in revenues for Q1 2025, driven by a 90% growth in sales of Zola coconut water, while also achieving significant reductions in operating expenses and a net income of $2.6 million.
Business Developments: The company is progressing with its business combination with Roosevelt Resources, having amended their agreement to provide more certainty regarding ownership ratios, and has successfully sold patents to eliminate $1 million in liabilities.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
